Safety Alert

# Title Type of news Date Link of news
77 Safety Signal of Baricitinib and the Potential Risk of Diverticulitis Signal
76 Safety Signal of Cardiac Failure associated with the use of Ibrutinib Signal
75 Safety Signal of Skin Cancer associated with the use of Methotrexate Signal
74 Switching between Warfarin Brands and The Importance of Close Monitoring of INR Precautions
73 Hydroxychloroquine and Chloroquine Alone and in Combination with Azithromycin and Potential Increased Risk of Heart Rhythm Problems Warning
72 SFDA Recommendations for Healthcare Professionals Regarding The Unapproved Use of Hydroxychloroquine and Chloroquine in Treatment of COVID-19 Warning
71 SFDA Advises Continued Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) in Patients with COVID-19 Precautions
70 SFDA’s Advice on the Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Patients with COVID-19 Precautions
69 Risk of potentially fatal respiratory depression with benzodiazepines and opioids Warning
68 Concern on Potential Risk of Respiratory Depression Associated with Gabapentinoids (pregabalin and gabapentin) medications Warning
Displaying 111 - 120 of 187